SEC Form 4 · accession 0001209191-18-055999
ARROWHEAD PHARMACEUTICALS, INC. · ARWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Brian Leone
Officer — VP, Strategic Bus. Initiatives
Period of report
Oct 19, 2018
Accepted (ET)
Oct 23, 2018 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 19, 2018 | M | 30,000 | $2.79 | A | 160,000 | D | |
| Common Stock | Oct 19, 2018 | M | 34,375 | $6.15 | A | 194,375 | D | |
| Common Stock | Oct 19, 2018 | M | 66,762 | $7.75 | A | 261,137 | D | |
| Common StockF1,F2 | Oct 19, 2018 | S | 131,137 | $13.49 | D | 130,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF3 | $2.79 | Oct 19, 2018 | M | 30,000 | D | Jul 20, 2013 | Jul 20, 2023 | Common Stock | 30,000 | 190,000 | D |
| Stock OptionsF3 | $6.15 | Oct 19, 2018 | M | 34,375 | D | Jan 1, 2016 | Jan 1, 2026 | Common Stock | 34,375 | 155,625 | D |
| Stock OptionsF3 | $7.75 | Oct 19, 2018 | M | 66,762 | D | Mar 6, 2015 | Mar 6, 2025 | Common Stock | 66,762 | 88,863 | D |
Explanation of responses
- F1The price reported on Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.10 to $13.56, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- F2Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
- F3Represents first vesting date. Option vests over four years from date of grant.